GIM
PFE icon

Gold Investment Management’s Pfizer PFE Stock Holding History

Gold Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
57,668
+1,202
+2% +$31.4K 0.38% 71
2026
Q1 		$1.59M Buy
56,466
+1,074
+2% +$28.6K 0.49% 66
2025
Q4 		$1.38M Buy
55,392
+1,394
+3% +$35.2K 0.44% 69
2025
Q3 		$1.38M Buy
53,998
+1,117
+2% +$27.6K 0.46% 69
2025
Q2 		$1.31M Buy
52,881
+80
+0.2% +$1.87K 0.49% 66
2025
Q1 		$1.34M Buy
52,801
+2,488
+5% +$65.1K 0.57% 65
2024
Q4 		$1.33M Buy
50,313
+265
+0.5% +$7.19K 0.56% 63
2024
Q3 		$1.45M Sell
50,048
-3,668
-7% -$107K 0.61% 61
2024
Q2 		$1.5M Buy
53,716
+120
+0.2% +$3.3K 0.64% 59
2024
Q1 		$1.49M Buy
53,596
+7,526
+16% +$209K 0.6% 61
2023
Q4 		$1.33M Buy
+46,070
New +$1.39M 0.57% 63

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gold Investment Management's PFE Position: Q2 2026 in Review

Gold Investment Management increased its Pfizer (PFE) stake by 2.1% in Q2 2026, buying an estimated $31.4K and bringing the position to 57,668 shares worth $1.39M. The position accounts for 0.38% of the portfolio, ranked #71.

Gold Investment Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.59M in Q1 2026. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Gold Investment Management held 57,668 shares of Pfizer worth $1.39M as of Q2 2026.
  • Gold Investment Management bought 1,202 Pfizer shares in Q2 2026, an estimated $31.4K.
  • Pfizer made up 0.38% of Gold Investment Management's portfolio in Q2 2026, its #71 holding.
  • Gold Investment Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Gold Investment Management's Pfizer position peaked at $1.59M in Q1 2026.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Gold Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.